White tea extract induces apoptosis in non-small cell lung cancer cells: The role of peroxisome proliferator-activated receptor-γ and 15-lipoxygenases

Cancer Prevention Research

Volumn 3, Issue 9, 2010, Pages 1132-1140

  Mao, Jenny T ^a,b   Nie, Wen Xian ^b   Tsu, I Hsien ^b   Jin, Yu Sheng ^b   Rao, Jian Yu ^b   Lu, Qing Yi ^c   Zhang, Zuo Feng ^d   Go, Vay Liang W ^c   Serio, Kenneth J ^e  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SCRIPPS GREEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; CAFFEIC ACID; CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GREEN TEA EXTRACT; MESSENGER RNA; NORDIHYDROGUAIARETIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; UNCLASSIFIED DRUG; WHITE TEA EXTRACT;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN INDUCTION; TEA; WHITE TEA;

ANILIDES; APOPTOSIS; ARACHIDONATE 15-LIPOXYGENASE; CARCINOMA, NON-SMALL-CELL LUNG; CATECHIN; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONE ANTAGONISTS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LUNG NEOPLASMS; PLANT EXTRACTS; PPAR GAMMA; TEA; TUMOR CELLS, CULTURED;

EID: 77956396930     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0264     Document Type: Article

References (38)

1. Tijburg LB, Mattern T, Folts JD, Weisgerber UM, Katan MB. Tea flavonoids and cardiovascular disease: a review. Crit Rev Food Sci Nutr 1997;37:771-85. (Pubitemid 127348901)
2. Dreosti IE. Antioxidant polyphenols in tea, cocoa, and wine. Nutrition 2000;16:692-4.
3. Siddiqui IA, Adhami VM, Saleem M, Mukhtar H. Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res 2006;50:130-43.
4. Yuan JM, Gao YT, Yang CS, Yu MC. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer 2007;120:1344-50.
5. Yang CS, Sang S, Lambert JD, Hou Z, Ju J, Lu G. Possible mechanisms of the cancer-preventive activities of green tea. Mol Nutr Food Res 2006;50:170-5. (Pubitemid 43325658)
6. Dashwood RH. Early detection and prevention of colorectal cancer. Oncol Rep 1999;6:277-81.
7. Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1β-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 2002;33:1097-105.
8. Metz N, Lobstein A, Schneider Y, et al. Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract. Nutr Cancer 2000;38:60-4.
9. Luceri C, Caderni G, Sanna A, Dolara P. Red wine and black tea polyphenols modulate the expression of cycloxygenase-2, inducible nitric oxide synthase and glutathione-related enzymes in azoxymethane-induced f344 rat colon tumors. J Nutr 2002;132:1376-9. (Pubitemid 34606479)
10. Lu G, Liao J, Yang G, Reuhl KR, Hao X, Yang CS. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res 2006;66:11494-501.
11. Record IR, Dreosti IE. Protection by tea against UV-A + B-induced skin cancers in hairless mice. Nutr Cancer 1998;32:71-5.
12. Sato D. Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea. Int J Urol 1999;6:93-9. (Pubitemid 30406818)
13. de Boer JG, Yang H, Holcroft J, Skov K. Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus. Nutr Cancer 2004;50:168-73.
14. Santana-Rios G, Orner GA, Xu M, Izquierdo-Pulido M, Dashwood RH. Inhibition by white tea of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine- induced colonic aberrant crypts in the F344 rat. Nutr Cancer 2001;41:98-103.
15. Chung FL, Morse MA, Eklind KI, Xu Y. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea. Ann N Y Acad Sci 1993;686:186-201.
16. Santana-Rios G, Orner GA, Amantana A, Provost C, Wu SY, Dashwood RH. Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat Res 2001;495:61-74. (Pubitemid 32614183)
17. Ara G, Teicher BA. Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostaglandins Leukot Essent Fatty Acids 1996;54:3-16.
18. Mao JT, Cui X, Reckamp K, et al. Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer. Clin Lung Cancer 2005;7:30-9.
19. Shankaranarayanan P, Nigam S. IL-4 induces apoptosis in A549 lung adenocarcinoma cells: evidence for the pivotal role of 15- hydroxyeicosatetraenoic acid binding to activated peroxisome proliferator-activated receptor γ transcription factor. J Immunol 2003;170:887-94.
20. Shappell SB, Gupta RA, Manning S, et al. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor γ and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 2001;61:497-503.
21. Dashwood WM, Orner GA, Dashwood RH. Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations. Biochem Biophys Res Commun 2002;296:584-8.
22. Sartippour M, Heber D, Lu Q, Ma M, Go VL, Nguyen M. Green tea inhibits breast cancer growth and angiogenesis. Nut Cancer 2001;40:149-56. (Pubitemid 34274921)
23. Chow HH, Hakim IA, Vining DR, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 2005;11:4627-33.
24. Mao JT, Tsu IH, Dubinett SM, et al. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Clin Cancer Res 2004;10:6872-8.
25. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000;405:421.
26. Satoh T, Toyoda M, Hoshino H, et al. Activation of peroxisome proliferator-activated receptor-γ stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma. Oncogene 2002;21:2171-80.
27. Chen GG, Xu H, Lee JF, et al. 15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor γ-dependent pathway. Int J Cancer 2003;107:837-43.
28. Hsi LC, Wilson L, Nixon J, Eling TE. 15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor γ via the MAPK signaling pathway. J Biol Chem 2001;276:34545-52. (Pubitemid 37384446)
29. Shureiqi I, Jiang W, Zuo X, et al. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A 2003;100:9968-73.
30. Lai CK, Phillips GD, Jenkins JR, Holgate ST. The effect of inhaled 15-(s)-hydroxyeicosatetraenoic acid (15-HETE) on airway calibre and non-specific responsiveness in normal and asthmatic human subjects. Eur Respir J 1990;3:38-45.
31. Moreno JJ. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem Pharmacol 2009;77:1-10.
32. Chang TH, Szabo E. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer. Cancer Res 2000;60:1129-38. (Pubitemid 30129556)
33. Jin YH, Yoo KJ, Lee YH, Lee SK. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J Biol Chem 2000;275:30256-63.
34. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
35. Muto S, Yokoi T, Gondo Y, et al. Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice. Carcinogenesis 1999;20:421-4. (Pubitemid 29112629)
36. Orner GA, Dashwood WM, Blum CA, Diaz GD, Li Q, Dashwood RH. Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of β-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 2003;24:263-7.
37. Bishop-Bailey D, Hla T. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Δ12, 14-prostaglandin J2. J Biol Chem 1999;274:17042-8. (Pubitemid 129519033)
38. Hashimoto K, Ethridge RT, Saito H, Rajaraman S, Evers BM. The PPARγ ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis. Pancreas 2003;27:58-66.